CAT<sub>3</sub>, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O<sup>6</sup>-methylguanine DNA methyltransferase expression

Xiaoguang Chen(Henan University of Science and Technology)
OncoTargets and Therapy
June 1, 2018
Cited by 21


Related Papers